Opioid Abuse: The Limits Of Industry’s Response
Executive Summary
PhRMA is endorsing dispensing limits on opioids and pledging to support a public/private partnership to develop new treatments and alternatives. But members of a Presidential Commission didn’t seem impressed.
You may also be interested in...
Mandatory Provider Training For Opioids Embraced By PhRMA
Trade association members also commit tens of millions of dollars to set up addiction prevention programs and create new health care tools.
White House Opioid Report Urges Better Access To Overdose Treatment; Mandatory Prescriber Education
Pricing of anti-addiction therapies could come under more pressure from HHS if Trump Administration accepts White House commission recommendation to declare public health emergency on opioid crisis.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.